Beth E Snitz1, Yuefang Chang2, Dana L Tudorascu2, Oscar L Lopez2, Brian J Lopresti2, Steven T DeKosky2, Michelle C Carlson2, Ann D Cohen2, M Ilyas Kamboh2, Howard J Aizenstein2, William E Klunk2, Lewis H Kuller2. 1. From the Departments of Neurology (B.E.S., O.L.L., W.E.K.), Neurological Surgery (Y.C.), Medicine (D.L.T.), Radiology (B.J.L.), Psychiatry (A.D.C., H.J.A., W.E.K.), Human Genetics (M.I.K.), and Epidemiology (L.H.K.), University of Pittsburgh, PA; Department of Neurology (S.T.D.), University of Florida, Gainesville; and Department of Mental Health (M.C.C.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. snitzbe@upmc.edu. 2. From the Departments of Neurology (B.E.S., O.L.L., W.E.K.), Neurological Surgery (Y.C.), Medicine (D.L.T.), Radiology (B.J.L.), Psychiatry (A.D.C., H.J.A., W.E.K.), Human Genetics (M.I.K.), and Epidemiology (L.H.K.), University of Pittsburgh, PA; Department of Neurology (S.T.D.), University of Florida, Gainesville; and Department of Mental Health (M.C.C.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Abstract
OBJECTIVE: To explore long-term predictors of avoiding β-amyloid (Aβ) deposition and maintaining unimpaired cognition as outcomes in the oldest old. METHODS: In a longitudinal observational cohort study, 100 former participants of the Ginkgo Evaluation of Memory Study (GEMS; 2000-2008) completed biannual Pittsburgh compound B-PET imaging and annual clinical-cognitive evaluations beginning in 2010. Most recent Aβ status and cognitive status were selected for each participant. Longitudinal outcomes included change in serial Aβ and cognitive tests. Baseline predictors from GEMS included neuropsychological tests, daily functioning, APOE genotype, lifestyle variables, occupational measures, health history, sleep, subjective memory, physical and cognitive activities, depressive symptoms, and physical performance and health indices, among others. RESULTS: Mean age at the last cognitive evaluation was 92.0 (range 86-100) years. Mean follow-up time from baseline to last measured Aβ status was 12.3 (SD 1.9) years and to last cognitive evaluation was 14.1 (SD 1.9) years. The APOE*2 allele predicted last Aβ status (n = 34 Aβ negative vs n = 66 Aβ positive). Baseline cognition predicted cognitive status (n = 30 unimpaired vs n = 70 impaired). Predictors of cognitive status among Aβ-positive participants only (n = 14 normal cognition vs n = 52 impaired) were baseline cognitive test scores and smoking history. Baseline pulse pressure predicted longitudinal Aβ increase; paid work engagement and life satisfaction predicted less cognitive decline. CONCLUSIONS: The APOE*2 allele and lower pulse pressure predict resistance to Aβ deposition in advanced aging. Cognitive test scores 14 years prior, likely reflecting premorbid abilities, predict cognitive status and maintenance of unimpaired cognition in the presence of Aβ. Several lifestyle factors appear protective.
OBJECTIVE: To explore long-term predictors of avoiding β-amyloid (Aβ) deposition and maintaining unimpaired cognition as outcomes in the oldest old. METHODS: In a longitudinal observational cohort study, 100 former participants of the Ginkgo Evaluation of Memory Study (GEMS; 2000-2008) completed biannual Pittsburgh compound B-PET imaging and annual clinical-cognitive evaluations beginning in 2010. Most recent Aβ status and cognitive status were selected for each participant. Longitudinal outcomes included change in serial Aβ and cognitive tests. Baseline predictors from GEMS included neuropsychological tests, daily functioning, APOE genotype, lifestyle variables, occupational measures, health history, sleep, subjective memory, physical and cognitive activities, depressive symptoms, and physical performance and health indices, among others. RESULTS: Mean age at the last cognitive evaluation was 92.0 (range 86-100) years. Mean follow-up time from baseline to last measured Aβ status was 12.3 (SD 1.9) years and to last cognitive evaluation was 14.1 (SD 1.9) years. The APOE*2 allele predicted last Aβ status (n = 34 Aβ negative vs n = 66 Aβ positive). Baseline cognition predicted cognitive status (n = 30 unimpaired vs n = 70 impaired). Predictors of cognitive status among Aβ-positive participants only (n = 14 normal cognition vs n = 52 impaired) were baseline cognitive test scores and smoking history. Baseline pulse pressure predicted longitudinal Aβ increase; paid work engagement and life satisfaction predicted less cognitive decline. CONCLUSIONS: The APOE*2 allele and lower pulse pressure predict resistance to Aβ deposition in advanced aging. Cognitive test scores 14 years prior, likely reflecting premorbid abilities, predict cognitive status and maintenance of unimpaired cognition in the presence of Aβ. Several lifestyle factors appear protective.
Authors: Timothy M Hughes; Lewis H Kuller; Emma J M Barinas-Mitchell; Eric M McDade; William E Klunk; Ann D Cohen; Chester A Mathis; Steven T Dekosky; Julie C Price; Oscar L Lopez Journal: JAMA Neurol Date: 2014-05 Impact factor: 18.302
Authors: M Rusanen; S Rovio; T Ngandu; A Nissinen; J Tuomilehto; H Soininen; M Kivipelto Journal: Dement Geriatr Cogn Disord Date: 2010-09-20 Impact factor: 2.959
Authors: Michelle C Carlson; Jeanine M Parisi; Jin Xia; Qian-Li Xue; George W Rebok; Karen Bandeen-Roche; Linda P Fried Journal: J Int Neuropsychol Soc Date: 2011-12-15 Impact factor: 2.892
Authors: Beth E Snitz; Ellen S O'Meara; Michelle C Carlson; Alice M Arnold; Diane G Ives; Stephen R Rapp; Judith Saxton; Oscar L Lopez; Leslie O Dunn; Kaycee M Sink; Steven T DeKosky Journal: JAMA Date: 2009-12-23 Impact factor: 56.272
Authors: Nienke Legdeur; Maryam Badissi; Stephen F Carter; Sophie de Crom; Aleid van de Kreeke; Ralph Vreeswijk; Marijke C Trappenburg; Mardien L Oudega; Huiberdina L Koek; Jos P van Campen; Carolina J P W Keijsers; Chinenye Amadi; Rainer Hinz; Mark F Gordon; Gerald Novak; Jana Podhorna; Erik Serné; Frank Verbraak; Maqsood Yaqub; Arjan Hillebrand; Alessandra Griffa; Neil Pendleton; Sophia E Kramer; Charlotte E Teunissen; Adriaan Lammertsma; Frederik Barkhof; Bart N M van Berckel; Philip Scheltens; Majon Muller; Andrea B Maier; Karl Herholz; Pieter Jelle Visser Journal: BMC Geriatr Date: 2018-11-26 Impact factor: 3.921
Authors: Kay Deckers; Martin P J van Boxtel; Olga J G Schiepers; Marjolein de Vugt; Juan Luis Muñoz Sánchez; Kaarin J Anstey; Carol Brayne; Jean-Francois Dartigues; Knut Engedal; Miia Kivipelto; Karen Ritchie; John M Starr; Kristine Yaffe; Kate Irving; Frans R J Verhey; Sebastian Köhler Journal: Int J Geriatr Psychiatry Date: 2014-12-12 Impact factor: 3.485